A center for improving treatments for asthma and allergies
Official title: RhoFED AA-SCCC
Funded at Rho Federal Systems Division, INC. · NIH-11082214 · Data updated 2026-11-12
This study is setting up a special center to help find better ways to treat and prevent asthma and allergies, working with experts to make sure everything is done safely and accurately for patients like you.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rho Federal Systems Division, INC. NIH-funded |
| Lab location | 1 site (Durham, UNITED STATES) |
| Project start | May 5, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $8,956,667 |
| NIH project number | 5U01AI178772-03 |
| Project ID | NIH-11082214 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals with allergic diseases or asthma who are seeking new treatment options.
✕Less likely to help
Patients with non-allergic respiratory conditions may not receive benefits from this research.
What this research studies
This research establishes a center dedicated to coordinating clinical trials and studies focused on asthma and allergic diseases. It aims to develop new strategies for treatment and prevention by managing research protocols, statistical analysis, and biological specimen repositories. The center will work closely with experienced scientists and clinical investigators to ensure efficient and ethical conduct of studies, while continuously monitoring data accuracy and patient safety.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive strategies for patients suffering from asthma and allergies.
How similar studies have gone: Previous research in similar areas has shown promise in developing effective treatments for asthma and allergies, indicating a potential for success in this approach.
Where this research is happening
-
Rho Federal Systems Division, INC.
Durham, United States Active
Researchers
- Principal investigator: Visness, Cynthia M — Rho Federal Systems Division, INC.
- Study coordinator: Visness, Cynthia M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.